These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35801241)

  • 1. Identification of Two Subtypes and Prognostic Characteristics of Lung Adenocarcinoma Based on Pentose Phosphate Metabolic Pathway-Related Long Non-coding RNAs.
    Liu C; Wang Y
    Front Public Health; 2022; 10():902445. PubMed ID: 35801241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
    Fan Z; Wang Y; Niu R
    Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of RNA Methylation Modification-immune-related lncRNA Molecular Subtypes and Prognostic Scoring System in Lung Adenocarcinoma.
    Wang J; Shu J
    Curr Med Chem; 2024; 31(12):1539-1560. PubMed ID: 37680151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.
    Peng F; Wang R; Zhang Y; Zhao Z; Zhou W; Chang Z; Liang H; Zhao W; Qi L; Guo Z; Gu Y
    Mol Cancer; 2017 Jun; 16(1):98. PubMed ID: 28587642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes.
    Cao P; Zhao B; Xiao Y; Hu S; Kong K; Han P; Yue J; Deng Y; Zhao Z; Wu D; Zhang L; Li F
    Biomed Res Int; 2022; 2022():7587398. PubMed ID: 35178454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Tumor Immune Microenvironment and Prognosis of m6A-Related IncRNAs in Lung Adenocarcinoma.
    Shen Y; Hou N; Han F; Chen B; Shi J; Sun X
    Crit Rev Eukaryot Gene Expr; 2022; 32(5):77-91. PubMed ID: 35993946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of sialylation-related long non-coding RNAs in lung adenocarcinoma.
    Wang B; Hou C; Yu X; Liu J; Wang J
    Sci Rep; 2024 Apr; 14(1):8879. PubMed ID: 38632255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer.
    Liu X; Gao J; Wang J; Chu J; You J; Jin Z
    Exp Biol Med (Maywood); 2021 Mar; 246(5):547-559. PubMed ID: 33203236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma.
    Ren J; Wang A; Liu J; Yuan Q
    Bioengineered; 2021 Dec; 12(1):4331-4348. PubMed ID: 34338158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
    Salavaty A; Rezvani Z; Najafi A
    J Cell Mol Med; 2019 Aug; 23(8):5600-5617. PubMed ID: 31211495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma.
    Hui H; Li D; Lin Y; Miao H; Zhang Y; Li H; Qiu F; Jiang B
    J Thorac Dis; 2023 Jul; 15(7):3919-3933. PubMed ID: 37559652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27.
    Qiu M; Xu Y; Wang J; Zhang E; Sun M; Zheng Y; Li M; Xia W; Feng D; Yin R; Xu L
    Cell Death Dis; 2015 Aug; 6(8):e1858. PubMed ID: 26291312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an immune-related six-long noncoding RNA signature as a novel prognosis biomarker for adenocarcinoma of lung.
    Miao H; Chen D; Li R; Hu J; Chen Y; Xu C; Wen Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33324975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 15. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma.
    Zhuang J; Chen Z; Chen Z; Chen J; Liu M; Xu X; Liu Y; Yang S; Hu Z; He F
    Respir Res; 2022 May; 23(1):123. PubMed ID: 35562727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs.
    Feng Y; Sun X; Yang T; Han J; Zhou D; Ren H; Sheng Y; Wang Y
    Comput Math Methods Med; 2022; 2022():2807354. PubMed ID: 35529265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B; Chen Y; Yang J
    Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.
    Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L
    Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
    Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
    Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.